세계의 분자진단 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for molecular diagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Molecular Diagnostics Market Size (2025E): USD 25.2 Billion
• Projected Market Value (2032F): USD 43.4 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 8.1%

Molecular Diagnostics Market - Report Scope:

Molecular diagnostics involves the analysis of biological markers in the genome and proteome to diagnose and monitor disease, detect risk, and decide which therapies will work best for individual patients. This segment has become increasingly essential in clinical practice due to its accuracy, speed, and potential for personalization of treatment. The molecular diagnostics market serves hospitals, diagnostic laboratories, research institutes, and homecare settings, encompassing technologies like PCR, NGS, microarrays, and in situ hybridization. Market expansion is being driven by rising demand for early disease detection, increased prevalence of infectious and chronic diseases, and continuous innovations in molecular technologies.

Market Growth Drivers:

The global molecular diagnostics market is propelled by several key factors, including the rising burden of infectious diseases such as COVID-19, HIV, hepatitis, and tuberculosis. Additionally, the growing emphasis on personalized medicine and targeted therapies necessitates accurate molecular testing. The increasing use of point-of-care diagnostics, along with the proliferation of companion diagnostics in oncology, further enhances the demand. Technological advancements in automation, real-time PCR, and next-generation sequencing are improving diagnostic efficiency, speed, and sensitivity, thereby expanding market adoption across healthcare systems.

Market Restraints:

Despite promising growth, the molecular diagnostics market faces certain challenges, such as high cost of instruments and tests, especially in low- and middle-income countries. Reimbursement limitations, particularly for novel diagnostic tools, restrict accessibility. Regulatory complexities and time-consuming approval processes also act as barriers to innovation and market entry. Furthermore, the shortage of skilled laboratory professionals and infrastructure constraints in resource-limited settings hinder the adoption of advanced molecular diagnostics.

Market Opportunities:

The molecular diagnostics market presents significant growth opportunities fueled by expanding applications in oncology, genetic testing, pharmacogenomics, and infectious disease management. The integration of artificial intelligence and bioinformatics for data analysis is transforming the diagnostic landscape. Increasing investments in research and public-private collaborations are promoting innovation and commercialization of cutting-edge molecular tests. Growing awareness about early disease detection and rising healthcare spending, especially in emerging markets, are expected to unlock new avenues for market expansion. Additionally, the development of portable and easy-to-use molecular diagnostic kits for point-of-care testing is set to revolutionize patient care in both urban and remote areas.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the molecular diagnostics market globally?
• Which technologies and applications are most widely adopted in clinical molecular diagnostics?
• How are emerging technologies like NGS and AI impacting the competitive landscape?
• Who are the leading companies in the molecular diagnostics market, and what strategies are they using to stay competitive?
• What are the key trends and future outlook for the global molecular diagnostics market?

Competitive Intelligence and Business Strategy:

These companies focus on expanding their test portfolios, developing multiplex and syndromic testing panels, and enhancing automation and throughput of diagnostic systems. Collaborations with biotechnology firms, diagnostic labs, and healthcare institutions drive access and adoption. Furthermore, companies are prioritizing regulatory approvals, market expansion in developing economies, and customer-centric strategies to reinforce their global presence.

Key Companies Profiled:

• Becton, Dickinson and Company
• Bio-Rad Laboratories In
• Merck KgaA
• Thermo Fisher Scientific Inc
• Agilent Technologies, Inc.
• F. Hoffman - La Roche Ltd.
• Illumina, Inc.
• Qiagen N.V.
• Hologic Inc.
• Siemens Healthineers AG
• Seegene, Inc.
• DiaSorin S.p.A
• Grifols, S.A.
• bioMerieux
• QuidelOrtho Corporation
• RapidBio
• Abbott Laboratories
• Danaher Corporation

Molecular Diagnostics Market Research Segmentation:

By Product Type:

• Instruments
  • * Polymerase Chain Reaction (PCR) Systems
  • * Hybridization (In-Situ Hybridization & Fish) Systems
  • * DNA Sequencing and Next-Generation Sequencing Platforms
  • * Microarrays
• Reagent
  • * Antibodies
  • * DNA Template
  • * DNA Polymerase
  • * Oligonucleotide Primers
  • * Deoxyribonucleotide Triphosphate (dNTPs)
  • * Buffer
• Assay Kits
• Consumables

By Disease Area:

• Infectious Disease
• Diabetes
• Cardiology
• Oncology
• Nephrology
• Autoimmune Disease
• Dermatology
• Wound Care
• Others

By End-use:

• Hospitals & Clinics
• Diagnostics Laboratories
• Academic and Research Institutes
• Biopharmaceutical Companies

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Molecular Diagnostics Market Snapshot 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Industry Developments and Key Market Events
• 1.5. Demand Side and Supply Side Analysis
• 1.6. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definitions
• 2.2. Value Chain Analysis
• 2.3. Macro-Economic Factors
  • 2.3.1. Global GDP Outlook
  • 2.3.2. Global GDP Outlook
  • 2.3.3. Global economic Growth Forecast
  • 2.3.4. Global Urbanization Growth
  • 2.3.5. Other Macro-economic Factors
• 2.4. Forecast Factors - Relevance and Impact
• 2.5. COVID-19 Impact Assessment
• 2.6. PESTLE Analysis
• 2.7. Porter's Five Forces Analysis
• 2.8. Geopolitical Tensions: Market Impact
• 2.9. Regulatory and Technology Landscape

3. Market Dynamics

• 3.1. Drivers
• 3.2. Restraints
• 3.3. Opportunities
• 3.4. Trends

4. Price Trend Analysis, 2019-2032

• 4.1. Region-wise Price Analysis
• 4.2. Price by Segments
• 4.3. Price Impact Factors

5. Global Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 5.1. Key Highlights
• 5.2. Global Molecular Diagnostics Market Outlook: Product Type
  • 5.2.1. Introduction/Key Findings
  • 5.2.2. Historical Market Size (US$ Bn) Analysis by Product Type, 2019-2024
  • 5.2.3. Current Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 5.2.3.1. Instruments
      • 5.2.3.1.1. Polymerase Chain Reaction (PCR) Systems
      • 5.2.3.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 5.2.3.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 5.2.3.1.4. Microarrays
    • 5.2.3.2. Reagent
      • 5.2.3.2.1. Antibodies
      • 5.2.3.2.2. DNA Template
      • 5.2.3.2.3. DNA Polymerase
      • 5.2.3.2.4. Oligonucleotide Primers
      • 5.2.3.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 5.2.3.2.6. Buffer
    • 5.2.3.3. Assay Kits
    • 5.2.3.4. Consumables
  • 5.2.4. Market Attractiveness Analysis: Product Type
• 5.3. Global Molecular Diagnostics Market Outlook: Disease Area
  • 5.3.1. Introduction/Key Findings
  • 5.3.2. Historical Market Size (US$ Bn) Analysis by Disease Area, 2019-2024
  • 5.3.3. Current Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 5.3.3.1. Infectious Disease
    • 5.3.3.2. Diabetes
    • 5.3.3.3. Cardiology
    • 5.3.3.4. Oncology
    • 5.3.3.5. Nephrology
    • 5.3.3.6. Autoimmune Disease
    • 5.3.3.7. Dermatology
    • 5.3.3.8. Wound Care
    • 5.3.3.9. Others
  • 5.3.4. Market Attractiveness Analysis: Disease Area
• 5.4. Global Molecular Diagnostics Market Outlook: End-use
  • 5.4.1. Introduction/Key Findings
  • 5.4.2. Historical Market Size (US$ Bn) Analysis by End-use, 2019-2024
  • 5.4.3. Current Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 5.4.3.1. Hospitals & Clinics
    • 5.4.3.2. Diagnostics Laboratories
    • 5.4.3.3. Academic and Research Institutes
    • 5.4.3.4. Biopharmaceutical Companies
  • 5.4.4. Market Attractiveness Analysis: End-use

6. Global Molecular Diagnostics Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2024
• 6.3. Current Market Size (US$ Bn) Forecast, by Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia & Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. North America Market Size (US$ Bn) Forecast, by Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. North America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
  • 7.4.1. Instruments
    • 7.4.1.1. Polymerase Chain Reaction (PCR) Systems
    • 7.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
    • 7.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
    • 7.4.1.4. Microarrays
  • 7.4.2. Reagent
    • 7.4.2.1. Antibodies
    • 7.4.2.2. DNA Template
    • 7.4.2.3. DNA Polymerase
    • 7.4.2.4. Oligonucleotide Primers
    • 7.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
    • 7.4.2.6. Buffer
  • 7.4.3. Assay Kits
  • 7.4.4. Consumables
• 7.5. North America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
  • 7.5.1. Infectious Disease
  • 7.5.2. Diabetes
  • 7.5.3. Cardiology
  • 7.5.4. Oncology
  • 7.5.5. Nephrology
  • 7.5.6. Autoimmune Disease
  • 7.5.7. Dermatology
  • 7.5.8. Wound Care
  • 7.5.9. Others
• 7.6. North America Market Size (US$ Bn) Forecast, by End-use, 2025-2032
  • 7.6.1. Hospitals & Clinics
  • 7.6.2. Diagnostics Laboratories
  • 7.6.3. Academic and Research Institutes
  • 7.6.4. Biopharmaceutical Companies

8. Europe Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Europe Market Size (US$ Bn) Forecast, by Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. Italy
  • 8.3.3. France
  • 8.3.4. U.K.
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Rest of Europe
• 8.4. Europe Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
  • 8.4.1. Instruments
    • 8.4.1.1. Polymerase Chain Reaction (PCR) Systems
    • 8.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
    • 8.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
    • 8.4.1.4. Microarrays
  • 8.4.2. Reagent
    • 8.4.2.1. Antibodies
    • 8.4.2.2. DNA Template
    • 8.4.2.3. DNA Polymerase
    • 8.4.2.4. Oligonucleotide Primers
    • 8.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
    • 8.4.2.6. Buffer
  • 8.4.3. Assay Kits
  • 8.4.4. Consumables
• 8.5. Europe Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
  • 8.5.1. Infectious Disease
  • 8.5.2. Diabetes
  • 8.5.3. Cardiology
  • 8.5.4. Oncology
  • 8.5.5. Nephrology
  • 8.5.6. Autoimmune Disease
  • 8.5.7. Dermatology
  • 8.5.8. Wound Care
  • 8.5.9. Others
• 8.6. Europe Market Size (US$ Bn) Forecast, by End-use, 2025-2032
  • 8.6.1. Hospitals & Clinics
  • 8.6.2. Diagnostics Laboratories
  • 8.6.3. Academic and Research Institutes
  • 8.6.4. Biopharmaceutical Companies

9. East Asia Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. East Asia Market Size (US$ Bn) Forecast, by Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. East Asia Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
  • 9.4.1. Instruments
    • 9.4.1.1. Polymerase Chain Reaction (PCR) Systems
    • 9.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
    • 9.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
    • 9.4.1.4. Microarrays
  • 9.4.2. Reagent
    • 9.4.2.1. Antibodies
    • 9.4.2.2. DNA Template
    • 9.4.2.3. DNA Polymerase
    • 9.4.2.4. Oligonucleotide Primers
    • 9.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
    • 9.4.2.6. Buffer
  • 9.4.3. Assay Kits
  • 9.4.4. Consumables
• 9.5. East Asia Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
  • 9.5.1. Infectious Disease
  • 9.5.2. Diabetes
  • 9.5.3. Cardiology
  • 9.5.4. Oncology
  • 9.5.5. Nephrology
  • 9.5.6. Autoimmune Disease
  • 9.5.7. Dermatology
  • 9.5.8. Wound Care
  • 9.5.9. Others
• 9.6. East Asia Market Size (US$ Bn) Forecast, by End-use, 2025-2032
  • 9.6.1. Hospitals & Clinics
  • 9.6.2. Diagnostics Laboratories
  • 9.6.3. Academic and Research Institutes
  • 9.6.4. Biopharmaceutical Companies

10. South Asia & Oceania Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of SAO
• 10.4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
  • 10.4.1. Instruments
    • 10.4.1.1. Polymerase Chain Reaction (PCR) Systems
    • 10.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
    • 10.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
    • 10.4.1.4. Microarrays
  • 10.4.2. Reagent
    • 10.4.2.1. Antibodies
    • 10.4.2.2. DNA Template
    • 10.4.2.3. DNA Polymerase
    • 10.4.2.4. Oligonucleotide Primers
    • 10.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
    • 10.4.2.6. Buffer
  • 10.4.3. Assay Kits
  • 10.4.4. Consumables
• 10.5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
  • 10.5.1. Infectious Disease
  • 10.5.2. Diabetes
  • 10.5.3. Cardiology
  • 10.5.4. Oncology
  • 10.5.5. Nephrology
  • 10.5.6. Autoimmune Disease
  • 10.5.7. Dermatology
  • 10.5.8. Wound Care
  • 10.5.9. Others
• 10.6. South Asia & Oceania Market Size (US$ Bn) Forecast, by End-use, 2025-2032
  • 10.6.1. Hospitals & Clinics
  • 10.6.2. Diagnostics Laboratories
  • 10.6.3. Academic and Research Institutes
  • 10.6.4. Biopharmaceutical Companies

11. Latin America Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 11.1. Key Highlights
• 11.2. Pricing Analysis
• 11.3. Latin America Market Size (US$ Bn) Forecast, by Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of LATAM
• 11.4. Latin America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
  • 11.4.1. Instruments
    • 11.4.1.1. Polymerase Chain Reaction (PCR) Systems
    • 11.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
    • 11.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
    • 11.4.1.4. Microarrays
  • 11.4.2. Reagent
    • 11.4.2.1. Antibodies
    • 11.4.2.2. DNA Template
    • 11.4.2.3. DNA Polymerase
    • 11.4.2.4. Oligonucleotide Primers
    • 11.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
    • 11.4.2.6. Buffer
  • 11.4.3. Assay Kits
  • 11.4.4. Consumables
• 11.5. Latin America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
  • 11.5.1. Infectious Disease
  • 11.5.2. Diabetes
  • 11.5.3. Cardiology
  • 11.5.4. Oncology
  • 11.5.5. Nephrology
  • 11.5.6. Autoimmune Disease
  • 11.5.7. Dermatology
  • 11.5.8. Wound Care
  • 11.5.9. Others
• 11.6. Latin America Market Size (US$ Bn) Forecast, by End-use, 2025-2032
  • 11.6.1. Hospitals & Clinics
  • 11.6.2. Diagnostics Laboratories
  • 11.6.3. Academic and Research Institutes
  • 11.6.4. Biopharmaceutical Companies

12. Middle East & Africa Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 12.1. Key Highlights
• 12.2. Pricing Analysis
• 12.3. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. South Africa
  • 12.3.3. Northern Africa
  • 12.3.4. Rest of MEA
• 12.4. Middle East & Africa Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
  • 12.4.1. Instruments
    • 12.4.1.1. Polymerase Chain Reaction (PCR) Systems
    • 12.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
    • 12.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
    • 12.4.1.4. Microarrays
  • 12.4.2. Reagent
    • 12.4.2.1. Antibodies
    • 12.4.2.2. DNA Template
    • 12.4.2.3. DNA Polymerase
    • 12.4.2.4. Oligonucleotide Primers
    • 12.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
    • 12.4.2.6. Buffer
  • 12.4.3. Assay Kits
  • 12.4.4. Consumables
• 12.5. Middle East & Africa Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
  • 12.5.1. Infectious Disease
  • 12.5.2. Diabetes
  • 12.5.3. Cardiology
  • 12.5.4. Oncology
  • 12.5.5. Nephrology
  • 12.5.6. Autoimmune Disease
  • 12.5.7. Dermatology
  • 12.5.8. Wound Care
  • 12.5.9. Others
• 12.6. Middle East & Africa Market Size (US$ Bn) Forecast, by End-use, 2025-2032
  • 12.6.1. Hospitals & Clinics
  • 12.6.2. Diagnostics Laboratories
  • 12.6.3. Academic and Research Institutes
  • 12.6.4. Biopharmaceutical Companies

13. Competition Landscape

• 13.1. Market Share Analysis, 2025
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles
  • 13.3.1. Becton, Dickinson and Company
    • 13.3.1.1. Company Overview
    • 13.3.1.2. Product Portfolio/Offerings
    • 13.3.1.3. Key Financials
    • 13.3.1.4. SWOT Analysis
    • 13.3.1.5. Company Strategy and Key Developments
  • 13.3.2. Bio-Rad Laboratories In
  • 13.3.3. Merck KgaA
  • 13.3.4. Thermo Fisher Scientific Inc
  • 13.3.5. Agilent Technologies, Inc.
  • 13.3.6. F. Hoffman - La Roche Ltd.
  • 13.3.7. Illumina, Inc.
  • 13.3.8. Qiagen N.V.
  • 13.3.9. Hologic Inc.
  • 13.3.10. Siemens Healthineers AG
  • 13.3.11. Seegene, Inc.
  • 13.3.12. DiaSorin S.p.A
  • 13.3.13. Grifols, S.A.
  • 13.3.14. bioMerieux
  • 13.3.15. QuidelOrtho Corporation

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations